Total Payments
$1,861
2024 Payments
$560.74
Companies
12
Transactions
88
Medicare Patients
968
Medicare Billing
$60,210
Payment Breakdown by Category
Food & Beverage$1,861 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,861 | 88 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534.08 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $414.29 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $348.11 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $233.68 | 13 | $0 (2024) |
| Braintree Laboratories, Inc. | $86.45 | 4 | $0 (2023) |
| QOL Medical, LLC | $82.42 | 2 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $44.88 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $40.88 | 2 | $0 (2023) |
| Lilly USA, LLC | $24.32 | 1 | $0 (2024) |
| Olympus America Inc. | $20.58 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.74 | 23 | ABBVIE INC. ($191.86) |
| 2023 | $872.39 | 46 | ABBVIE INC. ($342.22) |
| 2022 | $317.84 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($214.83) |
| 2021 | $110.48 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($96.69) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Gastroenterology | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Immunology | ||||||
| 07/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $38.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Gastroenterology | ||||||
| 05/24/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Immunology | ||||||
| 04/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Immunology | ||||||
| 03/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $43.98 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 257 | 260 | $183,399 | $15,672 |
| 2022 | 5 | 203 | 209 | $130,090 | $12,045 |
| 2021 | 9 | 379 | 394 | $232,500 | $25,368 |
| 2020 | 3 | 129 | 131 | $57,477 | $7,126 |
Total Patients
968
Total Services
994
Medicare Billing
$60,210
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 102 | 103 | $64,900 | $5,776 | 8.9% |
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 67 | 69 | $43,986 | $3,692 | 8.4% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 31 | 31 | $23,444 | $1,883 | 8.0% |
| 00840 | Anesthesia for other procedure on lower abdomen | Facility | 2023 | 15 | 15 | $20,482 | $1,768 | 8.6% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 30 | 30 | $19,404 | $1,642 | 8.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 12 | 12 | $11,183 | $910.57 | 8.1% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 89 | 95 | $46,134 | $4,574 | 9.9% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 65 | 65 | $42,272 | $4,071 | 9.6% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 23 | 23 | $15,144 | $1,328 | 8.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 14 | 14 | $16,391 | $1,156 | 7.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 12 | 12 | $10,150 | $915.92 | 9.0% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 118 | 118 | $64,362 | $7,439 | 11.6% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 102 | 116 | $52,200 | $5,929 | 11.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 50 | 51 | $27,096 | $2,941 | 10.9% |
| 00840 | Anesthesia for procedure in lower abdominal cavity including use of an endoscope | Facility | 2021 | 17 | 17 | $20,066 | $2,392 | 11.9% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 30 | 30 | $21,512 | $1,922 | 8.9% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 22 | 22 | $18,218 | $1,718 | 9.4% |
| 00400 | Anesthesia for procedure on skin of arms, legs, or trunk | Facility | 2021 | 16 | 16 | $9,923 | $1,117 | 11.3% |
| 00145 | Anesthesia for retinal surgery | Facility | 2021 | 12 | 12 | $10,070 | $1,049 | 10.4% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2021 | 12 | 12 | $9,056 | $859.93 | 9.5% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 51 | 51 | $23,006 | $2,960 | 12.9% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 57 | 58 | $24,108 | $2,919 | 12.1% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 21 | 22 | $10,364 | $1,247 | 12.0% |
About Jennifer Miarecki
Jennifer Miarecki is a Nurse Anesthetist, Certified Registered healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1841693488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Miarecki has received a total of $1,861 in payments from pharmaceutical and medical device companies, with $560.74 received in 2024. These payments were reported across 88 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,861).
As a Medicare-enrolled provider, Miarecki has provided services to 968 Medicare beneficiaries, totaling 994 services with total Medicare billing of $60,210. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Hartford, CT
- Active Since 09/26/2014
- Last Updated 02/04/2015
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1841693488
Products in Payments
- ENTYVIO (Biological) $384.01
- XIFAXAN (Drug) $348.11
- RINVOQ (Biological) $272.56
- STELARA (Biological) $215.93
- SKYRIZI (Biological) $122.97
- SUTAB (Drug) $86.45
- SUCRAID (Drug) $82.42
- CREON (Drug) $73.06
- LINZESS (Drug) $51.58
- OCALIVA (Drug) $44.88
- DUPIXENT (Biological) $40.88
- GATTEX (Drug) $30.28
- OMVOH (Drug) $24.32
- Single Use Electrosurgical Snare SD-400 (Device) $20.58
- Talicia (Drug) $17.97
- TREMFYA (Drug) $17.75
- VIBERZI (Drug) $13.91
- BRIDION (Drug) $13.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Hartford
Krista Koerner, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $3,051
Nurse Anesthetist, Certified Registered $3,051
Kelly Buoniconti, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $2,108
Nurse Anesthetist, Certified Registered $2,108
Mr. Michael Zielinski, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,150
Nurse Anesthetist, Certified Registered $1,150
Kristen Paskewich, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $784.50
Nurse Anesthetist, Certified Registered $784.50
Jeffrey Wood, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $690.92
Nurse Anesthetist, Certified Registered $690.92
Peter Kucharas, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $556.00
Nurse Anesthetist, Certified Registered $556.00